Clinical Trial Update: Treatment With Autologous Skeletal Myoblasts [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating autologous skeletal myoblasts in patients with a history of myocardial infarction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Autologous Skeletal Myoblasts

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Old Myocardial Infarction | Phase 2 | Status: TERMINATED